Ono Motoharu, Yamada Kayo, Avolio Fabio, Afzal Vackar, Bensaddek Dalila, Lamond Angus I
Centre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
PLoS One. 2015 Sep 25;10(9):e0138668. doi: 10.1371/journal.pone.0138668. eCollection 2015.
We have previously reported an antisense technology, 'snoMEN vectors', for targeted knock-down of protein coding mRNAs using human snoRNAs manipulated to contain short regions of sequence complementarity with the mRNA target. Here we characterise the use of snoMEN vectors to target the knock-down of micro RNA primary transcripts. We document the specific knock-down of miR21 in HeLa cells using plasmid vectors expressing miR21-targeted snoMEN RNAs and show this induces apoptosis. Knock-down is dependent on the presence of complementary sequences in the snoMEN vector and the induction of apoptosis can be suppressed by over-expression of miR21. Furthermore, we have also developed lentiviral vectors for delivery of snoMEN RNAs and show this increases the efficiency of vector transduction in many human cell lines that are difficult to transfect with plasmid vectors. Transduction of lentiviral vectors expressing snoMEN targeted to pri-miR21 induces apoptosis in human lung adenocarcinoma cells, which express high levels of miR21, but not in human primary cells. We show that snoMEN-mediated suppression of miRNA expression is prevented by siRNA knock-down of Ago2, but not by knock-down of Ago1 or Upf1. snoMEN RNAs colocalise with Ago2 in cell nuclei and nucleoli and can be co-immunoprecipitated from nuclear extracts by antibodies specific for Ago2.
我们之前报道过一种反义技术——“snoMEN载体”,它利用经人工改造的人源小核仁RNA(snoRNA)靶向敲低蛋白质编码mRNA,改造后的snoRNA包含与mRNA靶标具有序列互补性的短区域。在此,我们描述了snoMEN载体用于靶向敲低微小RNA初级转录本的用途。我们记录了使用表达靶向miR21的snoMEN RNA的质粒载体在HeLa细胞中特异性敲低miR21的情况,并表明这会诱导细胞凋亡。敲低依赖于snoMEN载体中互补序列的存在,并且miR21的过表达可以抑制细胞凋亡的诱导。此外,我们还开发了用于递送snoMEN RNA的慢病毒载体,并表明这提高了在许多难以用质粒载体转染的人类细胞系中的载体转导效率。表达靶向pri-miR21的snoMEN的慢病毒载体转导可诱导人肺腺癌细胞凋亡,这些细胞表达高水平的miR21,但在原代人类细胞中则不会。我们表明,AGO2的小干扰RNA(siRNA)敲低可阻止snoMEN介导的miRNA表达抑制,但AGO1或UPF1的敲低则不会。snoMEN RNA与AGO2在细胞核和核仁中共定位,并且可以通过针对AGO2的特异性抗体从核提取物中进行免疫共沉淀。